Bihua Chen, 10% Owner at MoonLake Immunotherapeutics (MLTX), bought 800,000 shares at $50.00 ($40.0M) on 2023-06-30, disclosed to the SEC on 2023-07-05.
Open-market purchase of $40.0M MLTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| CRBP | SELL | 2025-12-15 | $688K | — | Filing → |
| AARD | BUY | 2025-02-19 | $3.0M | — | Filing → |
| BIOA | BUY | 2024-10-01 | $8.1M | — | Filing → |